Submitted by Anonymous (not verified) on 19 September 2025 - 15:38
Human medicines European public assessment report (EPAR): Jubbonti, denosumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jubbonti, denosumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised